Overview

Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DM

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the efficacy and safety of early combination therapy with Amaryl M with that of uptitration of metformin monotherapy in patients with type 2 DM inadequately controlled by prior monotherapy with metformin.
Phase:
Phase 4
Details
Lead Sponsor:
Handok Inc.
Handok Pharmaceuticals Co., Ltd.
Treatments:
Glimepiride
Metformin